Filter
1943
Text search:
alert
Featured
239
548
Language
Document type
1102
269
204
132
78
57
39
37
11
7
4
2
1
Countries / Regions
73
70
69
50
48
43
42
39
38
36
31
31
28
28
27
27
25
25
24
24
21
21
15
15
15
14
13
13
13
13
13
12
12
12
12
11
11
11
11
11
10
10
8
8
8
7
7
7
6
6
6
5
5
5
5
5
5
5
4
4
4
4
4
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
672
164
111
90
80
63
15
7
1
Toolboxes
256
188
163
116
65
58
56
54
52
51
45
41
36
35
35
34
32
24
20
15
12
11
6
4
Interim Technical Note
1. What is COVID-19?
2. Who is at most risk for COVID-19?
3. What is the risk of COVID-19 infection in humans in South Africa?
4. How is COVID-19 transmitted?
5. What are the signs and symptoms of COVID-19 infection in humans?
6. How is COVID-19 diagnosed?
7. How is COVID-19 infection
...
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 37.
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
This information leaflet is for general informative purposes only. It can be used in its current form or further modified and adapted by responsible authorities in each country as a country-specific guidance.
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
Framework for implementation.
The END TB Strategy.
Public Health Fact Sheet
Involving the Community in Responding to TB/HIV: Outcomes of Community-Led Monitoring and Advocacy
Accessed November 2017
The tuberculosis survival project .. your cure, your life
Accessed November 2017
the tuberculosis survival project … “…ta guérison, ta vie”
Accessed November 2017
Accessed November 2017
